Haw Par Corporation Ltd
SGX:H02
Haw Par Corporation Ltd
Revenue
Haw Par Corporation Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Haw Par Corporation Ltd
SGX:H02
|
Revenue
S$232.1m
|
CAGR 3-Years
28%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
WAVE Life Sciences Ltd
NASDAQ:WVE
|
Revenue
$113.3m
|
CAGR 3-Years
78%
|
CAGR 5-Years
51%
|
CAGR 10-Years
N/A
|
|
H
|
Hyphens Pharma International Ltd
SGX:1J5
|
Revenue
S$170.6m
|
CAGR 3-Years
12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
I
|
IX Biopharma Ltd
SGX:42C
|
Revenue
S$6.1m
|
CAGR 3-Years
59%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
See Also
What is Haw Par Corporation Ltd's Revenue?
Revenue
232.1m
SGD
Based on the financial report for Dec 31, 2023, Haw Par Corporation Ltd's Revenue amounts to 232.1m SGD.
What is Haw Par Corporation Ltd's Revenue growth rate?
Revenue CAGR 10Y
5%
Over the last year, the Revenue growth was 27%. The average annual Revenue growth rates for Haw Par Corporation Ltd have been 28% over the past three years , and 5% over the past ten years .